XML 41 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business segments and other information
12 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Business segments and other information
Business segments and other information
An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The Company does not evaluate its operating segments using discrete asset information.

The Company has the following six reportable operating segments: Vascular North America, Anesthesia North America, Surgical North America, EMEA, Asia and OEM. In connection with its presentation of segment information for its reportable operating segments, the Company also presents certain information pertaining to several immaterial operating segments in the “All other” category.

The Company’s reportable segments, other than the Original Equipment Manufacturer and Development Services ("OEM") segment, design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care, and generally serve two end markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.
The following tables present the Company’s segment results for the years ended December 31, 20162015 and 2014:
 
Year Ended December 31,
 
2016
 
2015
 
2014
 
(Dollars in thousands)
Revenue
 
 
 
 
 
Vascular North America
$
350,486

 
$
334,938

 
$
311,163

Anesthesia North America
198,772

 
189,297

 
183,909

Surgical North America
172,223

 
161,230

 
150,121

EMEA
510,934

 
514,443

 
593,065

Asia
249,416

 
241,726

 
237,696

OEM
160,990

 
149,399

 
143,966

All other
225,206

 
218,657

 
219,912

Consolidated net revenues
$
1,868,027

 
$
1,809,690

 
$
1,839,832

 
Year Ended December 31,
 
2016
 
2015
 
2014
 
(Dollars in thousands)
Operating Profit
 
 
 
 
 
Vascular North America
$
97,088

 
$
73,284

 
$
53,807

Anesthesia North America
55,544

 
48,311

 
34,566

Surgical North America
56,608

 
52,529

 
49,592

EMEA
84,392

 
92,326

 
114,650

Asia
75,770

 
67,887

 
62,152

OEM
33,641

 
33,162

 
30,635

All other
19,784

 
20,356

 
19,762

Total segment operating profit (1)
422,827

 
387,855

 
365,164

Unallocated expenses (2)
(103,374
)
 
(71,964
)
 
(80,302
)
Income from continuing operations before interest, loss on extinguishment of debt and taxes
$
319,453

 
$
315,891

 
$
284,862

(1)
Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2)
Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring and other impairment charges and gain on sale of assets.
 
Year Ended December 31,
 
2016
 
2015
 
2014
 
(Dollars in thousands)
Depreciation and Amortization
 
 
 
 
 
Vascular North America
$
36,260

 
$
37,159

 
$
35,701

Anesthesia North America
10,932

 
7,089

 
11,815

Surgical North America
10,459

 
12,289

 
6,316

EMEA
30,505

 
32,178

 
38,062

Asia
11,275

 
11,382

 
8,515

OEM
8,404

 
6,834

 
6,175

All other
20,511

 
18,403

 
20,446

Consolidated depreciation and amortization
$
128,346

 
$
125,334

 
$
127,030



Geographic data
The following tables provide total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2016, 2015 and 2014:
 
Year Ended December 31,
 
2016
 
2015
 
2014
 
(Dollars in thousands)
Net revenues (based on the Company's selling location):
 
 
 
 
 
United States
$
1,018,786

 
$
967,819

 
$
916,619

Other Americas
56,339

 
56,500

 
60,736

Europe
567,320

 
570,672

 
664,982

All other
225,582

 
214,699

 
197,495

 
$
1,868,027

 
$
1,809,690

 
$
1,839,832

Net property, plant and equipment:
 
 
 
 
 
United States
$
167,167

 
$
178,895

 
$
174,893

Malaysia
31,415

 
33,777

 
36,427

Ireland
36,569

 
33,219

 
29,746

Czech Republic
30,843

 
32,305

 
35,655

All other
36,905

 
37,927

 
40,714

 
$
302,899

 
$
316,123

 
$
317,435